← Leaderboards
Mark Orr
Hdt Bio Corporation
$599,629
Attributed
$599,629
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$599,629 · 1
By mechanism
N43$599,629 · 1
Top collaborators
No co-investigators on record.
Most similar at Hdt Bio Corporation
Same institution · by research overlap
- Amit Praful Khandhar$5,276,681
- Malcolm S Duthie$710,328
- Bryan Berube$575,195
Others in their field
Other Emerging Leaders on “Adjuvant”
- Ted Ross · University Of Georgia$68,763,143
- Jay Evans · University Of Montana$43,101,450
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Aaron Esser-Kahn · University Of Chicago$13,698,058
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
Research focus
AdjuvantAgonistAnimal ModelAntigensAvian InfluenzaBirdsCellular ImmunityDesignFormulationHumoral ImmunitiesImmunityImmunogenicInfluenzaInfluenza A Virus, H7n9 SubtypeInfluenza Virus VaccineNanoparticlePandemic DiseasePandemic InfluenzaPathogenicityPropertyProtective EfficacyResponseSmall Business Innovation Research GrantTechnology